Recorded Seminars

Please follow the link to be taken to the Department of Psychiatry’s YouTube channel which will contain current and future presentations by Penn faculty and staff as well as guest speakers. Please note that through the YouTube channel you can subscribe to become aware of any new presentations that are uploaded.

University of Pennsylvania : Psychiatry Seminars

PowerPoint Presentations
Predicting Smoking Relapse from Working Memory-Related Neural Activity

Unbridled Passions, Imaging the Brain Substrates Relapse Vulnerability

Brief Overview of Medications for OUD

Novel Treatments for Cocaine and Opioid Use Disorder

The Opioid Epidemic in Philadelphia

Using the EHR (electronic health record) data to understand risk for opioid use disorder (OUD Phenotypes

PET technology at Penn:  From Early Days to the New Explorer

Polygenic Risk Scores for Substance Use Disorders: Ready for Prime Time?

PET Quantification and Quality Control

Shared Genetic Influences Underlie Alcohol Use Disorder and Schizophrenia

The Neurobiology of Suicide Vulnerability, by Maria A. Oquendo, MD, PhD

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

Single Cell Transcriptomics in Schizophrenia Postmortem Brain: Moving Beyond Bulk Lysate

Images of a Pandemic: using PET to understand addiction

Metabolic ketosis as a potential treatment for alcohol use disorders

New Data: Do polygenic risk scores for Opioid Use Disorder (OUD) correlate with mu opioid receptor binding potential, indexed by [11-C] carfentanil binding?

Neuroimaging Pathways to Addiction: Holy Grails and Other Tales

Can molecular imaging help move forward endocannabinoid-focused treatments for psychiatric illness?

Kinetic Modeling in PET:  Madness in the Methods or Method to the Madness

Adventures at the intersection of HIV, neuroinflammation and drugs of abuse: new understanding and novel therapeutics

Independent Component Analysis (ICA) of MRI and PET, unmixing addiction in the brain

Discussion of: Auvity, et al. Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo

Discussion of: Canchy, et al. - Pharmacokinetics trumps pharmacodynamics during cocaine choice: a reconciliation with the dopamine hypothesis of addiction

Directing Bitopic or Bivalent Molecules to Dopamine D3 Receptors for the Treatment of Substance Use Disorders

Psilocybin-assisted psychotherapy to treat alcohol use disorder

Return of the psychedelics: Structure-activity relationship studies of N-benzyl-phenethylamines at the 5-HT2A receptor 

Back to Top